Pediatrix Medical Group Quarterly Income Statement
NYSE: MDHealth CareHospital/Nursing ManagementUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pediatrix Medical Group revenue and earnings
In the quarter ended Jun 30, 2026, Pediatrix Medical Group generated $487.8 million in revenue, up 4.0% from the same quarter a year earlier. Net income was $39.8 million (+1.5% year over year), for a net margin of 8.2% versus a median of 6.8% in the prior 5 quarters. Operating margin was 11.7%.
Diluted earnings per share came in at $0.49, up from $0.46.
Summary generated from market data by MetaCap's automated system. Methodology
Pediatrix Medical Group income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 487.78M | 476.20M | 493.77M | 492.88M | 468.84M | 458.36M | 502.36M | 511.16M | 504.30M | 495.10M | 496.44M | 506.61M |
| Revenue growth (YoY) | +4.04% | +3.89% | -1.71% | -3.58% | -7.03% | -7.42% | +1.19% | +0.90% | +0.74% | +0.83% | -3.39% | +3.41% |
| Operating Expenses | 430.86M | 434.54M | 444.98M | 424.82M | 408.98M | 426.26M | 463.07M | 477.33M | 662.02M | 479.21M | 607.93M | 466.34M |
| Operating Income | 56.92M | 41.66M | 48.79M | 68.05M | 59.87M | 32.10M | 39.29M | 33.83M | -157.72M | 15.89M | -111.49M | 40.27M |
| Interest Expense | 8.17M | 8.27M | 8.74M | 8.94M | 9.13M | 9.15M | 9.71M | 10.13M | 10.31M | 10.60M | 10.08M | 10.37M |
| Other Income (Expense) | -2.92M | -2.81M | -3.20M | 19.73M | -4.90M | -4.01M | -5.96M | -8.59M | -10.01M | -8.07M | -27.36M | -9.44M |
| Pretax Income | 54.00M | 38.84M | 45.59M | 87.78M | 54.97M | 28.09M | 33.33M | 25.23M | -167.73M | 7.82M | -138.85M | 30.83M |
| Income Tax | 14.16M | 9.27M | 11.91M | 16.07M | 15.71M | 7.35M | 2.85M | 5.79M | -14.70M | 3.79M | -14.56M | 9.44M |
| Net Income | 39.84M | 29.57M | 33.68M | 71.71M | 39.26M | 20.74M | 30.48M | 19.44M | -153.03M | 4.04M | -124.29M | 21.39M |
| Net Income growth (YoY) | +1.48% | +42.61% | +10.51% | +268.85% | — | +413.93% | — | -9.12% | -641.07% | -71.60% | -519.05% | -30.39% |
| EPS (Basic) | 0.50 | 0.37 | 0.41 | 0.85 | 0.46 | 0.25 | 0.37 | 0.23 | -1.84 | 0.05 | -1.50 | 0.26 |
| EPS (Diluted) | 0.49 | 0.36 | 0.40 | 0.84 | 0.46 | 0.24 | 0.37 | 0.23 | -1.84 | 0.05 | -1.50 | 0.26 |
| Shares Outstanding (Basic) | 79.44M | 80.88M | — | 84.61M | 84.80M | 84.44M | — | 83.89M | 83.33M | 82.86M | — | 82.54M |
| Shares Outstanding (Diluted) | 81.41M | 83.08M | — | 85.61M | 85.53M | 85.43M | — | 84.52M | 83.33M | 83.28M | — | 82.95M |
| EBITDA | 62.70M | 47.78M | 54.42M | 73.60M | 65.18M | 37.43M | 46.16M | 40.08M | -148.93M | 26.20M | -102.43M | 49.48M |
| Operating Margin | 11.67% | 8.75% | 9.88% | 13.81% | 12.77% | 7.00% | 7.82% | 6.62% | -31.28% | 3.21% | -22.46% | 7.95% |
| Net Margin | 8.17% | 6.21% | 6.82% | 14.55% | 8.37% | 4.52% | 6.07% | 3.80% | -30.34% | 81.00% | -25.04% | 4.22% |
This table shows 12 quarterly periods of Pediatrix Medical Group's income statement, from Q2 2026 back to Q3 2023, across 15 line items including revenue, operating expenses, operating income. Values in USD; B = billions, M = millions. Fiscal periods follow MD's reporting calendar. What is a income statement?